Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems. For conventional antibodies this involves either random pairing of VH and VL domains in combi...
Main Authors: | Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00619/full |
Similar Items
-
A qualitative study into the perceived barriers of accessing healthcare among a vulnerable population involved with a community centre in Romania
by: Siân George, et al.
Published: (2018-04-01) -
Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice
by: Tianyi Zhang, et al.
Published: (2018-09-01) -
Corrigendum: Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice
by: Tianyi Zhang, et al.
Published: (2019-03-01) -
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
by: Wang Y, et al.
Published: (2016-07-01) -
Accumulation of VH Replacement Products in IgH Genes Derived from Autoimmune Diseases and Anti-viral Responses in Human
by: Zhixin (Jason) eZhang
Published: (2014-07-01)